Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/2074/11531
DC FieldValueLanguage
dc.contributor.authorChatterjee, Chirantan
dc.contributor.authorKubo, Kensuke
dc.contributor.authorPingali, Viswanath
dc.date.accessioned2020-04-10T13:25:45Z-
dc.date.available2020-04-10T13:25:45Z-
dc.date.issued2013
dc.identifier.issn0012-9976
dc.identifier.urihttps://repository.iimb.ac.in/handle/2074/11531-
dc.description.abstractAs the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes in doctor behaviour, while pointing out potential issues with it. It argues that while the prices of older drugs might come down because of the new regulation, other issues pertaining to quality might arise.
dc.publisherEconomic and Political Weekly
dc.subjectPharmaceutical industry
dc.subjectHealth industry
dc.subjectMedicines
dc.subjectCrocin
dc.subjectParacetamol
dc.titleCrocin or paracetamol: what should the doctor prescribe?
dc.typeJournal Article
dc.pages20-22p.
dc.vol.noVol.48-
dc.issue.noIss.41-
dc.journal.nameEconomic and Political Weekly
Appears in Collections:2010-2019
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.